Key Findings from ASH 2024 in AML: Canadian Experts Weigh In

Key Findings from ASH 2024 in AML: Canadian Experts Weigh In
Videos
Podcasts
Icon Objectives

Learning Objectives

  1. Learning Objectives
    Describe key clinical trial data from 2024 ASH in the management of AML and the potential impact on Canadian practices.
  2. Discuss the most significant abstracts presented at the 2024 ASH in AML.
  3. Review the latest advances in the management of AML as they pertain to hematology, transplant, and pathology.”
Icon Chair Speaker

Speakers

Dr. Guillaume Richard-Carpentier (Speaker)
Dr. Christopher Lemieux (Moderator)

Videos

Podcasts

This program has been made possible through unrestricted support from Astellas.

To Top
Tagged